Inflammation and innate immune function in critical illness

Current Opinion in Pediatrics

Volumn 28, Issue 3, 2016, Pages 267-273

  Muszynski, Jennifer A ^a   Thakkar, Rajan ^a   Hall, Mark W ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

critical illness; immune suppression; immunoparalysis; inflammation; monocyte

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR;

ADVERSE OUTCOME; CRITICAL ILLNESS; DEATH; EX VIVO STUDY; IMMUNE DEFICIENCY; IMMUNOLOGY; INFECTION RISK; INFLAMMATION; INNATE IMMUNITY; INTENSIVE CARE UNIT; LYMPHOCYTE; MACROPHAGE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SECONDARY INFECTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE; MACROPHAGE ACTIVATION; METABOLISM; PATHOPHYSIOLOGY; PEDIATRICS;

BIOMARKERS; CRITICAL CARE; CRITICAL ILLNESS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA-DR ANTIGENS; HUMANS; IMMUNITY, INNATE; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MACROPHAGE ACTIVATION; PEDIATRICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84962053030     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000352     Document Type: Review

References (48)

1. Doughty LA, Kaplan SS, Carcillo JA. Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med. 1996; 24: 1137-1143.
2. Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007; 167: 1655-1663.
3. Balamuth F, Weiss SL, Hall M, et al. Identifying pediatric severe sepsis and septic shock: accuracy of diagnosis codes. J Pediatr. 2015; 167: 1295-1300.
4. Hall MW, Geyer SM, Guo CY, et al. Innate immune function and mortality in critically ill children with influenza: a multicenter study. Crit Care Med. 2013; 41: 224-236.
5. Muszynski JA, Nofziger R, Greathouse K, et al. Innate immune function predicts the development of nosocomial infection in critically injured children. Shock. 2014; 42: 313-321.
6. Wong HR, Cvijanovich N, Wheeler DS, et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med. 2008; 178: 276-282.
7. Ozturk H, Yagmur Y, Ozturk H. The prognostic importance of serum IL-1beta, IL-6, IL-8 and TNF-Alpha levels compared to trauma scoring systems for early mortality in children with blunt trauma. Pediatr Surg Int. 2008; 24: 235-239.
8. Wong HR, Weiss SL, Giuliano JS Jr, et al. Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS One. 2014; 9: e86242.
9. Reinhart K, Wiegand-Lohnert C, Grimminger F, et al. Assessment of the safety and efficacy of the monoclonal antitumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med. 1996; 24: 733-742.
10. Reinhart K, Menges T, Gardlund B, et al. Randomized, placebo-controlled trial of the antitumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: the RAMSES Study. Crit Care Med. 2001; 29: 765-769.
11. Panacek EA, Marshall JC, Albertson TE, et al. Efficacy and safety of the monoclonal antitumor necrosis factor antibody F(ab)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med. 2004; 32: 2173-2182.
12. Hall MW, Muszynski JA. Immune modulation in sepsis. J Pediatr Infect Dis. 2009; 4: 127-136.
13. Monneret G, Finck ME, Venet F, et al. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett. 2004; 95: 193-198.
14. Allen ML, Hoschtitzky JA, Peters MJ, et al. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med. 2006; 34: 2658-2665.
15. Hall MW, Gavrilin MA, Knatz NL, et al. Monocyte mRNA phenotype and adverse outcomes from pediatric multiple organ dysfunction syndrome. Pediatr Res. 2007; 62: 597-603.
16. Fumeaux T, Pugin J. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med. 2002; 166: 1475-1482.
17. Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation: rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996; 22: (Suppl 4): S474-481.
18. Hall MW, Knatz NL, Vetterly C, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011; 37: 525-532.
19. Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006; 32: 1175-1183.
20. Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. The Intravenous Immunoglobulin Collaborative Study Group. N Engl J Med. 1992; 327: 234-240.
21. Ho YP, Sheen IS, Chiu CT, et al. A strong association between downregulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol. 2006; 101: 1117-1124.
22. Venet F, Tissot S, Debard AL, et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med. 2007; 35: 1910-1917.
23. Docke WD, Hoflich C, Davis KA, et al. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem. 2005; 51: 2341-2347.
24. Albert M, Williamson D, Muscedere J, et al. Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study). Intensive Care Med. 2014; 40: 1313-1322.
25. Mella C, Suarez-Arrabal MC, Lopez S, et al. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis. 2013; 207: 564-573.
26. Cornell TT, Sun L, Hall MW, et al. Clinical implications and molecular mechanisms of immunoparalysis after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012; 143: 1160-1166.
27. Livingston DH, Appel SH, Wellhausen SR, et al. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg. 1988; 123: 1309-1312.
28. Ditschkowski M, Kreuzfelder E, Rebmann V, et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg. 1999; 229: 246-254.
29. Hershman MJ, Cheadle WG, Wellhausen SR, et al. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg. 1990; 77: 204-207.
30. Ploder M, Pelinka L, Schmuckenschlager C, et al. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock. 2006; 25: 129-134.
31. Wakefield CH, Carey PD, Foulds S, et al. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg. 1993; 80: 205-209.
32. Cheadle WG, Hershman MJ, Wellhausen SR, et al. HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg. 1991; 161: 639-645.
33. Asadullah K, Woiciechowsky C, Docke WD, et al. Immunodepression following neurosurgical procedures. Crit Care Med. 1995; 23: 1976-1983.
34. Boddie DE, Currie DG, Eremin O, et al. Immune suppression and isolated severe head injury: a significant clinical problem. Br J Neurosurg. 2003; 17: 405-417.
35. Woiciechowsky C, Schoning B, Lanksch WR, et al. Mechanisms of brainmediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med. 1999; 77: 769-780.
36. Abe R, Hirasawa H, Oda S, et al. Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J Surg Res. 2008; 147: 1-8.
37. Allen ML, Peters MJ, Goldman A, et al. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med. 2002; 30: 1140-1145.
38. Cornell TT, Sun L, Hall MW, et al. Clinical implications and molecular mechanisms of immunoparalysis after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012; 143: 1160-1166.
39. Westendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production in meningococcal disease. Lancet. 1997; 349: 1912-1913.
40. Reinke P, Volk HD. Diagnostic and predictive value of an immune monitoring program for complications after kidney transplantation. Urol Int. 1992; 49: 69-75.
41. Haveman JW, van den Berg AP, van den Berk JM, et al. Low HLA-DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake. Transpl Infect Dis. 1999; 1: 146-152.
42. Hoffman JA, Weinberg KI, Azen CG, et al. Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients. Transpl Infect Dis. 2004; 6: 147-155.
43. Muszynski JA, Nofziger R, Greathouse K, et al. Early adaptive immune suppression in children with septic shock: a prospective observational study. Crit Care. 2014; 18: R145.
44. Muszynski JA, Frazier E, Nofziger R, et al. Red blood cell transfusion and immune function in critically ill children: a prospective observational study. Transfusion. 2015; 55: 766-774.
45. Docke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med. 1997; 3: 678-681.
46. Nakos G, Malamou-Mitsi VD, Lachana A, et al. Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med. 2002; 30: 1488-1494.
47. Rosenbloom AJ, Linden PK, Dorrance A, et al. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients. Chest. 2005; 127: 2139-2150.
48. Meisel C, Schefold JC, Pschowski R, et al. Granulocyte-macrophage colonystimulating factor to reverse sepsis-Associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med. 2009; 180: 640-648.